・Adaptive Biotechnologies (ADPT) is a commercial-stage biotech with strong technical momentum. ・Shares are up 250% in the past year and just hit a new three-year high. ・ADPT maintains a 100% “Buy” ...

Get the latest federal technology news delivered to your inbox. The congressional working group on the national security ramifications of biotechnology is angling to publish and deliver new policy ...

Over the past decade, 32% of innovative drug approvals were sponsored by emerging biotech companies, suggesting that they are ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

Biotech stocks are showing signs of life after years of pressure from rate-driven factors, with several names posting significant gains following the release of positive clinical data. aTyr Pharma is ...

Driven by unhealthy diets, sedentary lifestyles, growing consumption of ultra-processed foods (UPFs), the latest Economic Survey (2025-26) flagged that obesity is fuelling a surge in NCDs such as ...

Tyra Biosciences, Inc. is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in FGFR biology. The Company's in-house ...